Results 31 to 40 of about 7,522 (217)

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience

open access: yes, 2022
Purpose: The objective of this study aimed to explore whether the original IVC regimen should be continued after the second TURBT or whether the IVC induction phase should be restarted from the beginning.
Zhimin Gao   +8 more
core   +1 more source

A Prospective Evaluation of Different Frailty Indices in Patients Undergoing Transurethral Resection of Bladder Tumor

open access: yesSociété Internationale d’Urologie Journal, 2023
BackgroundMost studies investigating the relationship between preoperative frailty and postoperative outcomes among bladder cancer patients only assess frailty retrospectively in patients who have undergone radical cystectomy.
Neebal Abunaser   +9 more
doaj   +1 more source

Transurethral resection of bladder tumour (TURBT) : Experience Ofa Tertiary Centre [PDF]

open access: yes, 2017
Objective: To show the epidemiological profile of patients who had transurethral resection of bladder tumours and the various histological types of bladder tumour at presentation.Methodology: A retrospective study on patients who had transurethral ...
Agbo, C.A., Agrawal, C.S., Niraj, T.
core   +1 more source

Bladder biopsies: A histopathological study

open access: yesJournal of Pathology of Nepal
Background: Urinary bladder lesion, both neoplastic and non-neoplastic, is a clinical condition with a significant impact on public health. Many risk factors like smoking, environmental exposures and increasing age are associated with neoplastic ...
Binaya Shrestha   +5 more
doaj   +1 more source

Comparing the short - term outcomes and complications of monopolar and bipolar transurethral resection of bladder tumors in patients with coronary artery disese: a prospective, randomized, controlled study

open access: yesInternational Brazilian Journal of Urology
Introduction: To compare the perioperative outcomes and complications of monopolar and bipolar transurethral resection of bladder tumors (TURBT) in patients with coronary artery disease (CAD). Materials and Methods: A total of 90 CAD patients with newly
Deniz Bolat   +4 more
doaj   +1 more source

A Case of Extravesical Metastases Occurring after Transurethral Resection of Non-Invasive Bladder Cancer

open access: yes대한영상의학회지, 2018
A transurethral resection of bladder tumor (TURBT) is the primary treatment modality for bladder cancer. The common complications of TURBT include urinary tract infections, a hemorrhage requiring transfusion, and bladder perforation.
Ga Ram Kang   +2 more
doaj   +1 more source

Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser En Bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial

open access: yesBladder Cancer, 2020
BACKGROUND: Ongoing efforts aim at overcoming the challenges of conventional transurethral resection of bladder tumor (TURBT) such as the high recurrence rate, difficulty of pathologic interpretation and complications including wall injury. OBJECTIVE: To
Dmitry Enikeev   +10 more
doaj   +1 more source

Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation

open access: yesAdvanced Science, EarlyView.
This work identifies acetylation‐dependent SDHA homeostasis as a determinant of tumor‐specific metabolic vulnerability. Guided by this mechanism, a modification‐selective inhibitor, ZPI‐3, selectively targets non‐acetylated SDHA, achieving tumor‐restricted SDH inhibition and effective bladder cancer control. Differential responses in clinical specimens
Kaikai Xu   +9 more
wiley   +1 more source

A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection

open access: yesWorld Journal of Surgical Oncology, 2017
Background Transurethral resection of bladder tumor (TURBT) is the standard approach to bladder tumors but suffers from several disadvantages. The aim of this study was to evaluate the safety and efficacy of a novel procedure of retrograde en bloc ...
Kai-Yan Zhang   +5 more
doaj   +1 more source

Aspirin‐Derived Salicyl‐CoA Drives Histone Lysine Salicylation Regulated by CBP and SIRT2

open access: yesAdvanced Science, EarlyView.
Aspirin‐derived salicyl‐CoA serves as a previously unrecognized acyl donor for protein lysine salicylation. This study identifies histone lysine salicylation as a reversible epigenetic modification regulated by CBP and SIRT2, expanding the biochemical actions of aspirin beyond its canonical acetylation‐dependent mechanisms and providing a new framework
Facai Zhang   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy